Table 1.
Patient demographic and clinical characteristics | (N = 92) |
mean ± SD | |
Age (years) | 42.4 ± 10.3 |
CD4 count at initiation (cells/mm3) | 213 ± 116 |
Duration of ART (years) | 5.6 ± 3.4 |
Duration of treatment on any NS-ART (years) | 2.2 ± 1.5 |
Duration of treatment on current NS-ART (years) | 2.1 ± 1.5 |
n (%) | |
Female gender | 52 (57) |
WHO Stage III | 59 (64) |
WHO Stage IV | 8 (9) |
CD4 count ≤ 350 cells/mm3 | 25 (27) |
Being treated with first-line NS-ART | 8 (9) |
Being treated with modified second-line NS-ART | 84 (91) |
SD = standard deviation; ART = antiretroviral therapy;
NS-ART = non-standard ART regimen